Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations
A 51-year-old man with a history of DVT diagnosed seven months ago presents to your clinic for follow up. He has no family history of blood clots. He has …
Category: Heme/Onc
Clinical Correlations
Should All Patients with Hepatitis C Be Screened for Hepatocelluar Carcinoma?
July 3, 2007
Should patients with Hepatitis C (HCV) with no evidence of cirrhosis undergo screening for hepatocellular carcinoma (HCC)? Is there any reason to check for HCC when the liver associated enzymes (LAEs) are normal?
-Sandeep Mangalmurti, PGY-2
Commentary by Mike Poles MD, …
Meeting Perspectives-ASCO 2007
June 26, 2007
Commentary By: Theresa Ryan, M.D. Assistant Professor, Division of Oncology
During the first five days in June, the American Society of Clinical Oncology met in Chicago for their 43rd annual meeting. The theme of this meeting was “Translating Research into Practice,†…
Recent Developments in the Treatment of Renal Cell Carcinoma
May 31, 2007
Commentary by Michael Seidman MD, Chief Oncology Fellow
New treatment options for both early and advanced Renal Cell Cancer have recently been published. Traditionally, treatment for early stage disease was partial or radical nephrectomy. In the …
New Guidelines on the Diagnosis and Treatment of Venous Thromboembolism-Part 2
April 19, 2007
Commentary By: Margaret Horlick, MD, PGY-3
New guidelines on the diagnosis and treatment of venous thromboembolism (VTE) were recently jointly issued by the American Academy of Family Physicians and the American College of Physicians. The guidelines are based on a systematic …
New Guidelines on the Diagnosis and Treatment of Venous Thromboembolism-Part 1
April 12, 2007
Commentary By: Margaret Horlick, MD, PGY-3
New guidelines on the diagnosis and treatment of venous thromboembolism (VTE) were recently jointly issued by the American Academy of Family Physicians and the American College of Physicians. The guidelines are based on a systematic …
Does Screening for Lung Cancer Improve Mortality?
April 10, 2007
Commentary By: Anna Dvorak, MDPGY-3
Lung cancer is the number one cause of cancer mortality in both men and women. Screening patients at risk for lung cancer might reduce mortality if it helps find cancers at an early stage while they are …
Will my breast cancer patient need adjuvant chemotherapy? Gene Micro array technology may help answer this question��
March 20, 2007
Commentary By Sandra D’Angelo, PGY-3
Breast cancer is the most common cancer diagnosed in women, second only to lung cancer as a leading cause of death from cancer. Experts state that approximately 210, 000 women will be diagnosed in …